Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply. | N Engl J Med;390(20): 1934-1935, 2024 May 30. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.

Hirschfield, Gideon M; Kremer, Andreas E; Levy, Cynthia.

Affiliation

Hirschfield GM; Toronto Centre for Liver Disease, Toronto, ON, Canada gideon.hirschfield@uhn.ca.
Kremer AE; University Hospital Zurich, Zurich, Switzerland.
Levy C; University of Miami, Miami, FL.

N Engl J Med ; 390(20): 1934-1935, 2024 May 30.

Article in En | MEDLINE | ID: mdl-38810195

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Cirrhosis, Biliary Limits: Humans Language: En Journal: N Engl J Med Year: 2024 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Cirrhosis, Biliary Limits: Humans Language: En Journal: N Engl J Med Year: 2024 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos